A phase II trial of prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-refractory metastatic castration-resistant prostate cancer (mCRPC).
Daniel Peter Petrylak
Research Funding - Progenics
David C. Smith
Research Funding - Progenics
Leonard Joseph Appleman
Research Funding - Progenics
Mark T. Fleming
Research Funding - Progenics
Arif Hussain
Research Funding - Progenics
Robert Dreicer
Research Funding - Progenics
A. Oliver Sartor
Research Funding - Progenics
Neal D. Shore
Research Funding - Progenics
Nicholas J. Vogelzang
Research Funding - Progenics
Hagop Youssoufian
Employment or Leadership Position - Progenics
Stock Ownership - Progenics
William C. Olson
Employment or Leadership Position - Progenics
Stock Ownership - Progenics
Nancy Stambler
Employment or Leadership Position - Progenics
Stock Ownership - Progenics
Kathleen Huang
Employment or Leadership Position - Progenics
Robert Joseph Israel
Employment or Leadership Position - Progenics
Stock Ownership - Progenics